What is pericardial heart disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Pericardial Heart Disease?

Pericardial heart disease is an umbrella term encompassing all pathological conditions affecting the pericardium—the double-walled sac surrounding the heart—including pericarditis (acute, subacute, chronic, and recurrent), pericardial effusion, cardiac tamponade, constrictive pericarditis, and pericardial masses 1.

Core Pathophysiology

The pericardium consists of two layers: a serous visceral layer (epicardium) and a fibrous parietal layer, which together enclose the pericardial cavity containing pericardial fluid 1. When disease occurs, the pericardial response typically involves:

  • Inflammation (fibrinous, noneffusive, or exudative processes)
  • Fluid accumulation (pericardial effusion)
  • Adhesive or fibrocalcific responses (constriction) 2

Main Clinical Syndromes

Pericardial disease manifests as five distinct clinical scenarios 1:

1. Pericarditis

  • Acute, subacute, chronic, or recurrent inflammatory process
  • Can be isolated or part of systemic disease
  • Presents with sharp, pleuritic chest pain worsening when supine (~90% of cases) 3
  • ECG shows widespread ST-segment elevation and PR depression (25-50% of cases) 3
  • Pericardial friction rub (<30% of cases) 3

2. Pericardial Effusion

  • Fluid accumulation in the pericardial space
  • Clinical presentation depends on speed of accumulation 1
  • Rapid accumulation (trauma, iatrogenic perforation) → immediate tamponade even with small volumes
  • Slow accumulation → large effusions over days to weeks before symptoms develop
  • Symptoms include dyspnoea, chest fullness, orthopnoea, and compression symptoms (nausea, dysphagia, hoarseness, hiccups) 1

3. Cardiac Tamponade

  • Pan-cyclic compression of cardiac chambers by increased pericardial fluid
  • Cardiac chambers compete for fixed intrapericardial volume 2
  • Classic signs: elevated jugular venous pressure, pulsus paradoxus, diminished heart sounds 1
  • Results in diastolic dysfunction and reduced cardiac output 2

4. Constrictive Pericarditis

  • Pericardium limits diastolic filling
  • Causes dissociation of intracardiac and intrathoracic pressures 2
  • Heightened ventricular interdependence
  • Elevated and equal venous and ventricular diastolic pressures 2

5. Pericardial Masses

  • Less common manifestation requiring imaging evaluation 1

Etiological Framework

Pericardial disease can be primary (isolated to the pericardium) or secondary (part of systemic disease) 1:

Common causes in North America/Western Europe:

  • Idiopathic or viral (most common) 3
  • Post-cardiac procedures or operations 3
  • Post-cardiac injury syndromes (post-MI, post-pericardiotomy, post-traumatic) 1

Systemic disease associations 1:

  • Renal failure (uraemic pericarditis, dialysis pericarditis)
  • Autoimmune diseases (SLE, rheumatoid arthritis, scleroderma, Sjögren's syndrome)
  • Malignancy (higher risk with tamponade without inflammatory signs) 1
  • Tuberculosis (most common cause in endemic areas) 3

Diagnostic Approach

Transthoracic echocardiography is the primary diagnostic tool (Class I recommendation) 1, providing:

  • Detection and semiquantitative assessment of effusion size
  • Evaluation of hemodynamic effects
  • Portability and widespread availability

Additional imaging modalities 1:

  • CT and CMR should be considered for loculated effusions, pericardial thickening, masses, and associated chest abnormalities (Class IIa)
  • Chest X-ray recommended for suspected pleuropulmonary involvement (Class I)
  • CRP assessment recommended to evaluate inflammatory markers (Class I)

Clinical Significance

Pericardial disease is relatively common, accounting for up to 5% of emergency department visits for nonischemic chest pain 3. While often considered benign, complications include:

  • Recurrence in 15-30% of patients despite treatment 3
  • Constrictive pericarditis (<0.5% of acute cases) 3
  • Cardiac tamponade (<3% of acute cases) 3
  • Chronic disease with impaired quality of life in substantial proportion of patients 4

Critical pitfall: Pericardial diseases can imitate more common cardiac diseases, making diagnosis challenging 5. The absence of ECG abnormalities (particularly in renal failure patients) does not exclude pericarditis 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.